Scientech Research’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
Scientech Research's SRPT Position: Q2 2026 in Review
Scientech Research sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 33,008 shares — an estimated $718K sold.
Scientech Research first reported a position in SRPT in Q1 2025 and held it in 2 quarters. The position peaked at $968K in Q1 2025. 326 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- Scientech Research reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
- Scientech Research sold 33,008 Sarepta Therapeutics shares in Q2 2026, an estimated $718K.
- Scientech Research first reported a position in Sarepta Therapeutics in Q1 2025 and held it in 2 quarters.
- Scientech Research's Sarepta Therapeutics position peaked at $968K in Q1 2025.
- 326 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.